JF
FHTX icon

Jump Financial’s Foghorn Therapeutics FHTX Stock Holding History

Jump Financial’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
36,383
+22,643
+165% +$100K ﹤0.01% 1866
2026
Q1 		$65.7K Sell
13,740
-10,389
-43% -$57K ﹤0.01% 1776
2025
Q4 		$130K Buy
+24,129
New +$109K ﹤0.01% 1809

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jump Financial's FHTX Position: Q2 2026 in Review

Jump Financial increased its Foghorn Therapeutics (FHTX) stake by 165% in Q2 2026, buying an estimated $100K and bringing the position to 36,383 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #1866.

Jump Financial first reported a position in FHTX in Q4 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Jump Financial held 36,383 shares of Foghorn Therapeutics worth $178K as of Q2 2026.
  • Jump Financial bought 22,643 Foghorn Therapeutics shares in Q2 2026, an estimated $100K.
  • Foghorn Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1866 holding.
  • Jump Financial first reported a position in Foghorn Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.